Despite a number of studies on signal transduction in epidermal keratinocytes, very little is known about how signals move from the cytosole to the nucleus during the course of keratinocyte proliferation and differentiation. In this study, we first compared the expression patterns of the karyopherin a (KPNA) subtypes, and found that KPNA2, KPNA3, and KPNA4 were the major subtypes in both normal human epidermal keratinocytes (NHEKs) and normal human dermal fibroblasts (NHDFs). Stimulation with either transforming growth factor (TGF)-b 1 or IFN-g for 24 hours resulted in the downregulation of KPNA2 expression specifically in NHEK at both the mRNA and protein levels. Interestingly, IFN-g, but not TGF-b 1 , specifically downregulated KPNA2 expression at the promoter level, suggesting differential regulation of KPNA2 expression by IFN-g and TGF-b 1 . We then demonstrated that KPNA2 physically bound to IFN regulatory factor-1 (IRF-1), a transcription factor induced by IFN-g, and induced nuclear translocation of IRF-1 in NHEKs. We finally performed microarray and quantitative real-time PCR analysis for the mRNA expression pattern of NHEK with either overexpression or knockdown of KPNA2, and indicated KPNA2 involvement for various epidermal gene regulations such as involucrin. Our data suggest that KPNA2 may play an important role in the signal-transduction pathways that regulate epidermal proliferation and differentiation.
INTRODUCTION
Recent reports have indicated that there are multiple pathways for nucleocytoplasmic protein transport, which involve specific transporters recognizing specific sequences in target proteins, such as nuclear localization signals (NLSs). The NLS protein-receptor complex is then transported through the nuclear pore in an energy-dependent manner (Goldfarb et al., 2004; Pemberton and Paschel, 2005) . The importin/karyopherin superfamily consists of cytosolic receptors that recognize NLSs and dock the NLS-containing proteins at the nuclear pore complex on the nuclear membrane. Members of the karyopherin a (KPNA) family interact specifically with karyopherin b1 to form karyopherin a-b heterodimers, which affect the receptors' affinity for NLSs and docking at the nuclear pore complex. At least six KPNA isoforms have been reported to be ubiquitously expressed in human cells (Quensel et al., 2004) : KPNA1/importin a5 (Cortes et al., 1994; O'Neil and Palese, 1995) , KPNA2/importin a1 (Cuomo et al., 1994; Weis et al., 1995; Guillemain et al., 2002) , KPNA3/importin a4 (Köhler et al., 1997; Takeda et al., 1997; Nachury et al., 1998) , KPNA4/importin a3 (Köhler et al., 1997; Seki et al., 1997) , KPNA5/importin a6 (Köhler et al., 1997) , and KPNA6/ importin a7 (Köhler et al., 1997; Tsuji et al., 1997) . The different KPNA proteins show distinct NLS-binding specificities (Nadler et al., 1997; Köhler et al., 1999) , and members of this gene family exhibit selective expression in various tissues at both the mRNA and protein levels (Takeda et al., 1997; Nachury et al., 1998; Köhler et al., 2002) . There are, however, few reports concerning the expression and function of particular KPNA isoforms in the skin. Moreover, whether there are specific roles for each KPNA isoform during signal transduction in various tissues, including the skin, has not yet been determined.
Epidermal keratinocytes regulate their proliferation and differentiation by transducing signals from outside the cell membrane to the nucleus through nuclear pores, thereby regulating the expression of epidermal proliferation-and differentiation-specific genes. To maintain epidermal homeostasis and to respond to pathogenic processes, such as wounds or inflammatory conditions, entry of the signal mediators into the nucleus seems to be tightly regulated by KPNAs. This suggests that each KPNA may have a unique set of target proteins, although the precise mechanism has not been identified.
Here we report the first examination of the expression patterns of KPNAs in normal human epidermal keratinocytes (NHEKs) and normal human dermal fibroblasts (NHDFs) . In this study, we determined that KPNA2 expression in NHEKs, but not in NHDFs, is differentially regulated by transforming growth factor (TGF)-b 1 and IFN-g, both of which are established modulators of epidermal proliferation and differentiation. We also provide evidence that KPNA2 may mediate the translocation of epidermal differentiation-inducing signals into the nucleus, at least in part, by recruiting transcription factors such as IFN regulatory factor-1 (IRF-1), a mediator of IFN-g-induced epidermal differentiation (Odanagi et al., 2004) . The data shown here provide novel insights into the signal transduction in epidermal keratinocytes mediated by the nuclear transporter KPNA2.
RESULTS
Expression patterns of KPNA mRNAs in NHEK, HaCaT, and NHDF cells
The expressions of KPNA1, KPNA2, KPNA3, and KPNA4 mRNAs were detected in NHEK, HaCaT, and NHDF cells by Northern blot analysis. KPNA5 mRNA, however, did not produce sufficiently strong signals using this method, and was detected only by reverse transcription (RT)-PCR. In all three cell types, KPNA2, KPNA3, and KPNA4 seemed to be strongly expressed, whereas KPNA1 and KPNA5 were expressed with relatively low signals (Figure 1 ). After correction with the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression level, relative mRNA expression levels of KPNA1 and KPNA2 in NHEK cells were stronger than in NHDF cells.
Downregulation of KPNA2 mRNA expression by TGF-b 1 in NHEK cells TGF-b 1 treatment (5 ng/ml) of NHEK cells resulted in the selective and time-dependent downregulation of KPNA2 mRNA expression; a nearly 70% inhibition was observed after 24 hours (Po0.001) (Figure 2a) . Moreover, this TGF-b 1 -mediated inhibition was found to be dose dependent; an approximately 50% inhibition was observed after 24 hours with a dose of 5 ng/ml TGF-b 1 (Po0.001). At a dose of 10 ng/ ml TGF-b 1 , however, the KPNA2 mRNA level was not significantly different from that observed at a dose of 5 ng/ml. On the contrary, there were no remarkable changes in the KPNA2 mRNA levels in NHDF cells (Figure 2a and b) . The addition of cycloheximide (CHX) to the culture medium antagonized the effects of TGF-b 1 on KPNA2 mRNA expression in NHEK cells (Figure 2c ). For the other members Figure 1 . Expression patterns of KPNA mRNAs in NHEK, HaCaT, and NHDF cells. mRNA extracted from sub-confluent NHEK, HaCaT, and NHDF cells was subjected to Northern blot analysis for the human KPNA1, KPNA2, KPNA3, KPNA4, KPNA5, and GAPDH genes. Exposure time: KPNA2, KPNA3, and KPNA4 for 24 hours; KPNA1 and KPNA5 for 7 days. Data are representative of two independent experiments. (5 ng/ml) was antagonized by CHX treatment (10 mg/ml), which started 1 hour before TGF-b 1 administration. Data are expressed as means7SD from three independent experiments (*Po0.05 and **Po0.01 compared with the initial expression level by one-way ANOVA).
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Dual modulation of KPNA2 mRNA expression by IFN-c in NHEKs
Stimulation of NHEKs with 100 U/ml IFN-g specifically upregulated KPNA2 mRNA expression within 12 hours (Figure 3a) . The maximal expression level, which was approximately twice the initial expression level, was observed after 6-hour incubation (Po0.001). The expression level then gradually declined to about 40% of the initial expression level (Po0.05) after 48 hours, suggesting dual regulation of KPNA2 by IFN-g. Stimulation of cells with various concentrations of IFN-g for 48 hours resulted in the selective downregulation of KPNA2 mRNA expression; the smallest effective dose of IFN-g was 10 U/ml (Po0.001). There were no remarkable changes of KPNA2 mRNA expression in NHDF cells following IFN-g treatment (Figure 3a and b). CHX treatment antagonized both IFN-g-dependent upregulation and downregulation of KPNA2 mRNA expression in NHEKs (Figure 3c ). No significant change in the expression levels of other KPNA family members was observed after IFN-g stimulation (data not shown).
Time-dependent regulation of KPNA2 protein expression by TGF-b 1 and IFN-c TGF-b 1 stimulation (5 ng/ml) of NHEKs resulted in the downregulation of KPNA2 protein expression after 24 hours (Po0.001). Stimulation of NHEKs with 100 U/ml IFN-g initially upregulated KPNA2 protein expression after 6 hours (Po0.01), before the expression level gradually declined and was completely suppressed after 48 hours (Po0.001), suggesting dual regulation of KPNA2 protein expression by IFN-g (Figure 4 ). This KPNA2 protein regulation by IFN-g and TGF-b corresponds to the results obtained in the Northern blot analysis. To confirm the direct effects of TGF-b 1 and IFN-g for KPNA2 transcription, NHEKs were transiently transfected with KPNA2 promoter-luc plasmid pKPNA2-luc followed by TGF-b and IFN-g inoculation in the culture medium, and luciferase assays were performed. KPNA2 promoter activity was significantly suppressed by IFN-g (100 U/ml) after 12 and 24 hours (Po0.001), but no significant promoter regulation was observed in the early time point of IFN-g treatment or by TGF-b stimulations ( Figure 5 ).
Nuclear transport of IRF-1 with KPNA2
The induction of KPNA2 expression by IFN-g raised the possibility that KPNA2 functions to transport IFN-g-inducing transcription factors such as IRF-1, which is known to be upregulated by IFN-g in NHEK cells, into the nucleus. To test for an interaction between IRF-1 and KPNA2, we co-transfected COS-7 cells with expression vectors coding for myc-tagged IRF-1 and FLAG-tagged KPNA2, and performed immunoprecipitation assays using anti-FLAG M2 agarose. Immunoblotting analysis with both anti-myc antibodies NHEK cells were treated with either 5 ng/ml TGF-b 1 or 100 U/ml IFN-g, and subjected to Western blot analysis for KPNA2 expression. Data are expressed as means7SD from three independent experiments (*Po0.05 and **Po0.01 compared with the initial expression level by one-way ANOVA).
indicated that IRF-1 precipitated with anti-FLAG M2 agarose, demonstrating an association between IRF-1 and KPNA2 ( Figure 6a ). Moreover, COS-7 cells co-transfected with the myc-tagged KPNA2 and FLAG-tagged IRF-1 expression vectors also revealed co-precipitation of IRF-1 with KPNA2 ( Figure 6b ). Interaction of endogenous KPNA2 and IRF-1 in NHEK was then detected by immunoprecipitation using anti-IRF-1 antibody and Western blotting using anti-KPNA2 antibody ( Figure 6c ). These data suggest that KPNA2 might act to import IRF-1 into the nucleus in response to IFN-g stimulation.
To investigate the roles of KPNA2 in IRF-1 localization, we stimulated NHEK cells with 100 U/ml IFN-g with or without KPNA2 knockdown with KPNA2-directed small interfering RNA (siRNA). IRF-1, which was primarily observed in the cytoplasm of NHEK cells without stimulation, translocated to the nucleus after IFN-g stimulation (Figure 7) . After KPNA2 knockdown, however, IRF-1 was retained in the cytoplasm even after IFN-g stimulation, and some seemed to be colocalized with KPNA2 (Figure 7) , suggesting that IRF-1 localization into the nucleus following IFN-g treatment may be mediated by KPNA2.
Possible roles of KPNA2 in keratinocyte differentiation
To investigate the effects of KPNA2 on NHEK gene expression, we performed a single experiment of microarray analysis in conditions with either a high or a low KPNA2 expression level. One hundred and fifty-one genes were upregulated when KPNA2 was overexpressed in NHEK cells, whereas 608 genes were downregulated as a result of KPNA2 knockdown. Fifty-four genes were modulated under both conditions and therefore seemed to be putative genes specifically regulated by KPNA2 expression (Table 1) . Data mining with the 54 genes was performed using keratinocyte differentiation, a structural component of the epidermis, and epidermal development as key terms. The database mining extracted 10 genes, including involucrin, keratin 1, keratin 10, proline-rich protein 1A (SPRR1A), and small proline-rich protein 1B (SPRR1B) (Figure 8a ). To confirm the data of the microarray analysis, real-time RT-PCR was performed for involucrin mRNA expression in NHEKs. Involucrin mRNA was significantly upregulated in the condition of high KPNA2 expression level and downregulated in that of KPNA2 knockdown (Figure 8b ). We also confirmed no modulation of GAPDH gene expression in the same mRNA samples used in this study (data not shown). These data indicated that the function of KPNA2 is, at least in part, to recruit transcriptional regulators for keratinocyte differentiation to the nucleus.
DISCUSSION
In this paper, we demonstrated that among the KPNA subunits in NHEK cells, the expression of KPNA2 is specifically regulated by TGF-b 1 and IFN-g. TGF-b 1 , which is naturally expressed in the suprabasal cells of the epidermis, induces reversible growth arrest at the G1 phase of the cell cycle (Shipley et al., 1986; Alexandrow et al., 1995) , but does not contribute to terminal differentiation (George et al., 1990; Arany et al., 1996) . In contrast, IFN-g, which is primarily produced and secreted by Langerhans cells in normal epidermis, induces irreversible growth arrest in cultured keratinocytes (Saunders and Jetten, 1994) and promotes aberrant terminal differentiation (Brysk et al., 1991; Tamai et al., 1995) . Previous studies have revealed that transcription factors such as Myc, NF-kB (Nadler et al., 1997) , and Epstein-Barr virus nuclear antigen (EBNA) (Fischer et al., 1997) are target proteins of KPNA2. The expression and nuclear localization of c-myc, an essential transcription factor required to maintain cell growth in the basal layer of the epidermis (Pietenpol et al., 1990; Alexandrow et al., 1995) , are rapidly downregulated when keratinocytes are treated with TGF-b 1 (Coffey et al., 1988) , resulting in growth arrest in the G1 phase of the cell cycle (Pietenpol et al., 1990) . Therefore, we speculate that the inhibition of proliferation observed in NHEK cells following TGF-b 1 and IFN-g treatment may be a result of the downregulation of KPNA2 and impaired nuclear import of c-myc.
Whereas TGF-b 1 caused only the downregulation of KPNA2 expression, IFN-g treatment induced KPNA2 expression within an initial 12 hours followed by downregulation after 24 hours at both mRNA and protein levels. A previous study showed that transglutaminase and cornifin, both of which are marker genes of keratinocyte differentiation, were upregulated by IFN-g in 12-36 hours, indicating the promotion of keratinocyte terminal differentiation (Saunders and Jetten, 1994) . The parallel induction of KPNA2 and keratinocyte differentiation marker genes by IFN-g suggest that increased nuclear entry of KPNA2-mediated signals may be involved in the keratinocyte differentiation.
IFN-g directly inhibited KPNA2 promoter activity followed by suppression of KPNA2 expression at both mRNA and protein levels. However, early upregulation by IFN-g and downregulation by TGF-b 1 were not observed by the KPNA2 promoter assay. These results may be explained by the secondary effect caused by induced changes in growth arrest and keratinocyte differentiation, or this 1 kb promoter region may not contain a cis-element responsible for the modulation.
CHX antagonized the effects of both TGF-b 1 and IFN-g on KPNA2 mRNA expression, indicating that protein synthesis was required for KPNA2 regulation by these cytokines. There is evidence that, following IFN-g activation, STAT-1 enters the nucleus via a mechanism that is KPNA1/NPI-1 dependent and KPNA2/Rch1 independent (Sekimoto et al., 1997) . This STAT1/KPNA1 complex may regulate the protein synthesis required for the modulation of KPNA2 by IFN-g.
In this study, we also demonstrated for the first time that KPNA2 physically interacts with IRF-1, which is specifically induced in NHEK cells by IFN-g stimulation, and regulates the nuclear entry of IRF-1. Whereas IRF-1 mRNA expression remains high after treatment of keratinocytes with IFN-g after 48 hours (Odanagi et al., 2004) , KPNA2 expression was suppressed at this time point, suggesting that KPNA2 may play a pivotal role, if not exclusive, for the fine-tuning of IFN-g/IRF-1-dependent signal transduction during epidermal differentiation. A single microarray experiment with mRNA from KPNA2-overexpressed/ downregulated NHEKs extracted a putative list of 10 genes relating to keratinocyte differentiation, suggesting again that KPNA2 may function for the nuclear entry of signals for keratinocyte differentiation. Repeated experiments, however, must be performed to provide a final list of the genes regulated by KPNA2.
Although KPNA2 overexpression resulted in induction of several keratinocyte differentiation-marker genes, we could not observe apparent morphological changes as seen in differentiated keratinocytes. Taken together, KPNA2 seems to be involved in keratinocyte differentiation, but may not be sufficient for the full-differentiation induction by itself.
Aberrant expression of KPNA2 induced by IFN-g in the epidermis may be involved in disorders such as psoriasis, in which both proliferation and differentiation of epidermal keratinocytes are disorganized. Further elucidation of the functions of KPNAs in epidermal keratinocytes during physiological and pathological conditions may provide clues for developing novel therapeutic approaches to skin diseases.
MATERIALS AND METHODS

Reagents
Recombinant human TGF-b 1 and recombinant human IFN-g were purchased from Roche (Mannheim, Germany). Anti-human KPNA2 goat polyclonal antiserum, anti-human IRF-1 rabbit polyclonal antiserum, and horseradish peroxidase-conjugated donkey anti-goat IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-myc-tag monoclonal mouse antibodies and anti-FLAG mouse antibodies were obtained from MBL (Nagoya, Japan) and Sigma-Aldrich (St Louis, MO), respectively. Finally, horseradish peroxidase-conjugated donkey anti-rabbit IgG and horseradish peroxidase-conjugated sheep anti-mouse IgG were purchased from Amersham (Arlington Heights, IL). www.jidonline.org 1461 N Umegaki et al.
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Cell culture
NHEKs obtained from neonatal foreskin were purchased from Clonetics (San Diego, CA) and Cascade Biologics (Portland, OR). The cells were propagated in keratinocyte growth medium (Clonetics) containing recombinant human EGF (0.1 mg/ml), insulin (0.5 mg/ml), hydrocortisone (0.5 mg/ml), gentamicin (50 mg/ml), amphotericin B (50 ng/ml), and bovine pituitary extract (0.1 mg/ml), or in standard medium containing 0.06 mmol/ml Ca 2 þ (Epilife-KGM;
Cascade Biologics) supplemented with human EGF (0.1 mg/ml), insulin (10 mg/ml), hydrocortisone (0.5 mg/ml), gentamicin (50 mg/ml), amphotericin B (50 ng/ml), and 4% bovine pituitary extract at 371C under 5% CO 2 -95% air. Cells were passed by trypsinization and 50-60% confluents of the keratinocytes were used for each experiment at the third or fourth passage.
HaCaT, an immortalized, non-tumorigenic keratinocyte cell line (kindly provided by Dr Husenig), NHDF, and COS-7 cells were cultured in DMEM (Nakarai, Tokyo, Japan) containing 10% fetal bovine serum at 371C under 5% CO 2 -95% air. NHDFs at the fifth passage were used for the experiments. Before cytokine stimulation, sub-confluent NHDF cells were incubated for 24 hours in serum-free medium. Various doses of TGF-b 1 or IFN-g were then added to the medium and the cells were incubated as indicated. The study was conducted according to the Declaration of Helsinki Principles.
RNA isolation and Northern blot analysis
Total RNA was extracted from cells using an RNA isolation kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. mRNA (15-20 mg) from each sample were electrophoresed on 1% formaldehyde/agarose gels, transferred to nylon membranes (Zeta-Probe blotting membrane, Bio-Rad, Hercules, CA), and immobilized by shortwave UV irradiation (UV-Stratalinker 1800, Stratagene, La Jolla, CA). All KPNA probes were generated by RT-PCR, sequenced, and labeled with 32 P using a random prime labeling kit (Stratagene). Blots were hybridized with 32 P-labeled cDNA probes for KPNA1, KPNA2, KPNA3, KPNA4, and KPNA5 overnight at 431C in 50% deionized formamide and re-hybridized with GAPDH. The filters were washed in 2 Â standard sodium citrate and 0.1% SDS at room temperature and exposed to film at À801C for approximately 24 hours for KPNA2, KPNA3, and KPNA4 or for 1 week for KPNA1 and KPNA5. Hybridization signals were quantified with a densitometer. The differences were statistically examined using one-way analysis of variance (ANOVA).
Western blot analysis
Cells were washed twice with cold phosphate-buffered saline (PBS) and then lysed in radioimmunoprecipitation assay buffer (20 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, and 0.5 M EDTA at pH 7.4), supplemented with protease inhibitor cocktail (complete mini, Roche). After ultrasonication and removal of insoluble cell debris, the protein concentration in the supernatant was determined with Bio-Rad Protein Assay Dye Reagent Concentrate (Bio-Rad). For Western analysis, 100 mg of the proteins were electrophoresed on a 10% SDS polyacrylamide gel. After electrophoresis, the proteins were transferred to nitrocellulose membranes (Hybond-P, Amersham) in transfer buffer containing 100 mM TrisHCl, 192 mM glycine, and 20% methanol. Residual binding sites on the membranes were blocked with 2% skim milk in Tris-buffered saline overnight at room temperature. The blots were incubated with primary antibodies for at least 1 hour at room temperature, washed five times (5 minutes each) with Tris-buffered saline containing 0.05% Tween 20, and incubated with horseradish peroxidaseconjugated secondary antibodies for 1 hour at room temperature. After washing, the membranes were developed with an enhanced chemiluminescence system (ECL-plus; Amersham). Normalized densitometric values for the individual lanes in three independent experiments were averaged; data are represented as the means7SD.
Construction of KPNA2 promoter-luciferase plasmid PCR primers for amplification of KPNA2 promoter regions were designed to obtain 5 0 flanking DNA at positions from À1 to À1,000. PCR-amplified fragments were then inserted into the KpnI-HindIII site of the pGL3-basic vector (Promega, San Luis, CA) to generate pKPN2-luc plasmid. The sequences inserted into pGL3-basic vector were confirmed by direct sequencing.
Transient transfection and luciferase assay
NHEK cells placed into 12-well plates were transfected with 0.43 mg of pKPN2-luc plasmid and 0.17 mg of pRL-TK vector using TransIT-LT1 (Mirus, Bienne, Bern, Switzerland). At the time of the transfection, 5 ng/ml of TGF-b 1 or 100 U/ml of IFN-g were added into the medium and harvested by 100 ml of passive cell lysis buffer (Promega) after each time course. The dual luciferase reporter assay was performed by a Dual-Glo luciferase Assay kit (Promega). pRL-TK vector was used as internal control, and data were normalized by Renilla luciferase luminescence intensity. The experiments were performed in triplicate, and the differences were statistically examined using one-way ANOVA.
Construction of KPNA2 and IRF-1 expression vectors, and siRNA-mediated knockdown of KPNA2
To create the pCY4B-KPNA2, pCAGIp-FLAG-KPNA2, pCAGIp-myc-KPNA2, pCAGIp-FLAG-IRF-1, and pCAGIp-myc-IRF-1 expression vectors, full-length human KPNA2 and IRF-1 cDNAs were generated by RT-PCR with PfuUltra High-Fidelity DNA polymerase (Stratagene). The PCR products were sequenced and their sizes were verified by agarose gel electrophoresis. The products were then cut from the gel, purified using a QIAquick gel extraction kit (Qiagen), and cloned into the pCR-Blunt-TOPO vector (Invitrogen, Carlsbad, CA). To complete the recombination sites, an adapter PCR was performed as described in the Gateway manual (Invitrogen). The purified PCR products were also cloned into the pENTER/SD/D-TOPO vector (Invitrogen), and cDNA plasmids were converted into other expression vectors using the Gateway LR reaction (Invitrogen). The medical ethical committee of Osaka University Graduate School of Medicine approved all described studies. siRNAs specific for KPNA2 and its control stealth siRNA were designed and obtained from Invitrogen. We performed KPNA2 knockdown studies with siRNA, which ensured more than 50% suppression of KPNA2 mRNA and protein.
Immunoprecipitation analysis
COS-7 cells transiently transfected using FuGene 6 (Roche) with pCAGIp-FLAG-KPNA2 and pCAGIp-myc-IRF-1, or pCAGIp-FLAG-IRF-1 and pCAGIp-myc-KPNA2 were lysed in ice-cold EBL buffer (150 mM NaCl, 50 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesul- NHEK cells cultured on 100 mm dishes were lysed in PBS containing 0.5% Triton X and 5 mM EDTA with protease inhibitor cocktail and phosphatase inhibitor (Sigma). Cell extracts were incubated overnight with 2 mg of anti-IRF-1 antibodies or in the absence of antibodies at 41C. The immunoprecipitates were collected on protein A-Sepharose beads (Amersham) for 4 hours at 41C. After washing five times with lysis buffer, proteins bound to Sepharose beads were eluted by boiling in sample buffer. Western blotting was performed with anti-KPNA2 antibodies.
Immunohistochemistry NHEK cells were grown on tissue-culture-treated slides (Falcon, Becton Dickinson, Franklin Lakes, NJ) and transfected with or without KPNA2 siRNAs 24 hours before stimulation with 100 U/ml IFN-g. After about 12 hours, cells were fixed with 4% paraformaldehyde at room temperature for 1 hour. Cells were permeabilized using 0.1% Triton X-100 in PBS for 3 minutes. Slides were washed in PBS, and nonspecific sites were blocked with 2% skim milk in PBS overnight before the slides were incubated with anti-human IRF-1 rabbit polyclonal antibodies (1:500) and anti-human KPNA/Rch1 mouse mAbs (BD Biosciences, San Jose, CA) (1:1,000). Subsequently, cells were labeled with Alexa Fluor 488 donkey anti-rabbit IgG and Alexa Fluor 546 goat anti-mouse IgG secondary antibodies (Molecular Probes, Eugene, OR) for 3 hours. Cells were then washed five times with PBS. Finally, the slides were stained with 4 0 ,6-diamidino-2-phenylindole for 10 minutes at room temperature and mounted with Vectashield anti-fade solution (Vector Laboratories Inc., Burlingame, CA).
Microarray analysis
NHEK cells were transfected with the pCY4B or pCY4B-KPNA2 expression vectors using TransIT-LT1 (Mirus) and control or KPNA2 stealth siRNA using TransIT-TKO (Mirus). Total RNA was extracted with an RNA isolation kit (Qiagen). The Whole Human Oligo Microarray (Agilent Technology, Palo Alto, CA) included 44,287 clones printed on a glass slide. For hybridization, 500 ng of total RNA was labeled with Cy3 or Cy5 monoreactive dyes using a Low RNA Fluorescent Linear Amplification kit (Agilent Technology). Cy3-and Cy5-labeled cDNA probes were cleaned with RNeasy mini spin columns (Qiagen). The purified probes were resuspended in hybridization buffer, and hybridization was performed at 601C for 17 hours. The microarray slide was washed once with 6 Â standard sodium citrate and 0.005% Triton X-102 at room temperature for 10 minutes, and once with 0.1 Â standard sodium citrate and 0.005% Triton X-102 at 41C for 5 minutes. Microarray scannings were performed using the Agilent Technologies Microarray Scanner, and statistical analysis was performed using two-tailed t-tests (Po0.01). Data mining in the gene database was performed with keratinocyte differentiation, epidermal structural components, and epidermis development as search terms.
Quantitative real-time PCR
The NHEK cells that were used for microarray analysis were also examined by quantitative real-time PCR. After RNA isolation, RT reactions were performed using SuperScript III (Invitrogen). All TaqMan probes (KPNA2: Hs 00818252g1; GAPDH: Hs99999905m1; involucrin: Hs00846307s1) were ordered from ''Gene Expression Assays'' (Applied Biosystems Inc., Foster City, CA). GAPDH was used as an internal control for all PCR amplification reactions. Relative mRNA expression was quantified using the comparative C t (DC t ) method and expressed as 2 ÀDDC t .
Each assay was carried out in triplicate and expressed as mean7SD.
